1. MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
    Junwoo Lee et al, 2019, International Journal of Oncology CrossRef
  2. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells
    Seong Hye Park et al, 2016, Oncotarget CrossRef
  3. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
    Robin Schmitz et al, 2016, Oncotarget CrossRef
  4. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
    Robert Brenig et al, 2020, Life Science Alliance CrossRef
  5. Antitumoral Effects of Metformin in Ovarian Cancer
    Maritza P. Garrido et al, 2019, Metformin [Working Title] CrossRef
  6. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms
    Mei Peng et al, 2017, Cancer Treatment Reviews CrossRef
  7. TAM family proteins and therapy resistance
    Nellie K. McDaniel et al, 2020, Improving the Therapeutic Ratio in Head and Neck Cancer CrossRef
  8. TYRO3: A potential therapeutic target in cancer
    Pei-Ling Hsu et al, 2019, Experimental Biology and Medicine CrossRef
  9. The Multifaceted Roles of TAM Receptors during Viral Infection
    Zhao-Yang Wang et al, 2021, Virologica Sinica CrossRef
  10. Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
    Yoo Jin Na et al, 2021, The Korean Journal of Internal Medicine CrossRef
  11. Turmeric: A Review of Its Chemical Composition, Quality Control, Bioactivity, and Pharmaceutical Application
    Fan-Cheng Meng et al, 2018, Natural and Artificial Flavoring Agents and Food Dyes CrossRef
  12. Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance
    Larissa J. Sanches et al, 2022, Cell Biology International CrossRef
  13. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase
    Tatsuya Saito et al, 2020, Leukemia Research CrossRef
  14. Combinational strategies of metformin and chemotherapy in cancers
    Hui-Hui Zhang et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
  15. Anti‑Axl monoclonal antibodies attenuate the migration of MDA‑MB‑231 breast cancer cells
    Hong Chang et al, 2021, Oncology Letters CrossRef
  16. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections
    Sounak Ghosh Roy, 2020, TAM Receptors in Health and Disease CrossRef
  17. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
    Roberto Würth et al, 2016, Drug Discovery Today CrossRef
  18. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
    Sherri Smart et al, 2018, Cancers CrossRef
  19. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity
    Stanley G. Kimani et al, 2017, Scientific Reports CrossRef
  20. NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway
    Shanyu Fang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  21. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
    Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef
  22. G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models
    Hae Dong Kim et al, 2021, Frontiers in Pharmacology CrossRef
  23. Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells
    Maritza P. Garrido et al, 2018, Therapeutic Advances in Medical Oncology CrossRef
  24. Effect of metformin on Bax expression in pancreas and testis of normoglycemic albino rat: An immunohistochemical study
    Hagar A Hashish, 2020, Indian Journal of Clinical Anatomy and Physiology CrossRef